Case Report. A Case Report of Adult Acne


Acne vulgaris is among the commonest inflammatory skin diseases affecting pilosebaceous units. It occurs mainly in puberty and affects adolescents at the age of 14-19 years both females and males, in relation to sebum production of hair follicles under the action of sex hormones. Clinically the disease is presented with comedones, papules, pustules, nodules and scars in some cases. Seborrheic areas face, chest and back are affected. Recent epidemiologic studies have shown significant number of female patients aged over 25 years with acne and the term Adult onset acne (AOA)was established.The latter is manifested clinically in the lower third of the face. Primary etiological cause of AOAisahormonal imbalance, mainly hyperandrogenemia. Acase ofa25-year-old woman with adult acne and elevated levels of testosterone and prolactine is presented in this paper.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J. 1979;1(6171):1109-10.

  • 2. Ramos-e-Silva M, Ramos-e-Silva S, Carneiro S. Acne in women. Br J Dermatol. 2015;172(1):20-6.

  • 3. Seirafi H, Farnaghi F, Vasheghani-Farahani A, Alirezaie NS, Esfahanian F, Firooz A, et al. Assessment of androgens in women with adultonset acne. Int J Dermatol. 2007;46(11):1188-91.

  • 4. Kaur S, Verma P, Sangwan A, Dayal S, Jain VK. Etiopathogenesis and therapeutic approach to adult onset acne. Am J Clin Dermatol. 2006; 7(5):281-90.

  • 5. Kamangar F, Shinkai K. Acne in the adult female patient:apractical approach. Int J Derm. 2012;51:1162- 7 4 .

  • 6. Dreno B, Layton A, Zouboulis CC, Lopez- Estebaranz JL, Zalewska-Janowska A, Bagatin E, et al. Adult female acne:anew paradigm. J Eur Acad Dermatol Venereol. 2013;27(9):1063-70.

  • 7. Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy.Am J Clin Dermatol. 2006;7(5):281-90.

  • 8. Lolis MS, Bowe WP, Shalita AR. Acne and systemic disease. Med Clin North Am. 2009;93:1161-81.

  • 9. Harper JC. Evaluating hyperandrogenism:achallenge in acne management. J Drugs Dermatol. 2008;7:527- 3 0 .

  • 10. George R, Clarke S, Thiboutot D. Hormonal therapy for acne. Semin Cutan Med Surg. 2008;27:188-96.

  • 11.Mualla P, Ekşioğlu M. Serumgrowth hormone and insulin-like growth factor-1 levels in women with postadolescent acne.Turkderm. 2010;44:69-72.

  • 12. Rivera R, Guerra A. Management of acne in women over 25 years of age.Actas Dermosifiliogr. 2009;100:33-7.

  • 13. Adityan B, Kumari R, Thappa DM. Scoring systems in acne vulgaris. Indian J Dermatol Venereol Leprol. 2009;75:323-6.

  • 14. Hacivelioglu S, Gungor AN, Gencer M. Acne severity and the Global Acne Grading System in polycystic ovary syndrome. Int J Gynaecol Obstet. 2013;123(1):33-6.

  • 15. Lehmann PM. Rosacea - epidemiology, pathogenesis, clinical presentation, and treatment. Dtsch Arztebl. 2007;104:1741-6.

  • 16. Ljubojević S1, Lipozencić J, Turcić P. Perioral dermatitis. Acta Dermatovenerol Croat. 2008;16:96-100.

  • 17. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006;74:125-30.

  • 18. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA. 2004;292:726-35.

  • 19. Steinkellner A, Chen W, Denison SE. Adherence to oral contraception in women on Category Xmedications.Am J Med. 2010;123:929-34.

  • 20. Tan JK, Ediriweera C. Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne. Int J Womens Health. 2010;9:213-21.


Journal + Issues